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Penicillin wide availability in the mid-twentieth century
marked the beginning of the antibiotic era. Since then,
antibiotic treatments have saved millions of lives, revolu-
tionizing the treatment of infectious diseases worldwide
and increasing our life expectancy (Davies and Davies,
2010). However, the extensive use of antimicrobial drugs
has triggered what could be one of the biggest threats to
human, animal and environmental health in the 21st cen-
tury: antimicrobial resistance (AMR) (WHO, 2015). In
fact, some predictions estimate that deaths attributable
to AMR may rise from 700 000 to 10 million lives annu-
ally by 2050 (Brogan and Mossialos, 2016; Butler, et al.,
2017).
Infections caused by multidrug-resistant (MDR) strains
were first reported in hospital settings, where antimicro-
bial use was most prevalent. Nevertheless, nowadays
antibiotic compounds are essential not only for human
therapy but also for prophylaxis and growth promotion in
the animal food industry (Castanon, 2007). The expo-
sure to substantial quantities of antimicrobial compounds
in farm animals has made livestock products a potential
reservoir of antimicrobial-resistant genes (ARGs), raising
the chances of transmission to humans through the food
chain, by direct animal contact, and through the
environment (e.g. wastewater), contributing to the spread
of antibiotic resistance (Maestre-Carballa et al., 2019).
Evidence of the dissemination of MDR clones and
mobile genetic clusters by antibiotic resistance cassettes
via food chain from poultry to humans is presented by
Cohen and colleagues in a comprehensive paper in
Environmental Microbiology using 16 438 poultry and
27 489 clinical (human) Salmonella isolates (Cohen
et al., 2020). The study by Cohen et al. illuminates the
ecology and resistance mechanisms of 13 common poul-
try-associated Salmonella serovars demonstrating a high
MDR prevalence in a subset of the strains. This work
emphasizes the role of the poultry production industry as
a reservoir of epidemic MDR strains and mobile genetic
elements that confer resistance to medically relevant
antibiotics.
One of the first natural barriers in the fight against the
infection by antibiotic-resistant bacteria is the intestinal
microbiota. The gut microbiome is critical for homeosta-
sis in humans and animals (Clemente et al., 2012); how-
ever, the use of broad-spectrum antibiotics causes a
general imbalance of the resident flora (dysbiosis) that
can potentially have consequences for animal and
human health (Clemente et al., 2012; Cully, 2019). One
of these consequences is a disproportional increase in
the abundance of specific bacteria that may carry mobile
elements containing ARGs. The study by Dobrzanska
and colleagues (2020) in Microbial Biotechnology corre-
lates changes in gut microbiota composition, after pre-
ventive antibiotic therapy, with weight gain and disease
in calves. In this work, calves treated with Florfenicol
changed their gut microbiota composition with enrich-
ment of a facultative anaerobe Proteobacteria (mainly
E. coli) and consequently of E. coli mobile-mediated
ARGs that provided resistance to other drugs not admin-
istered to the calves. Antibiotic treated calves also
showed an increase in body weight compared to the
non-treated group, although both groups followed the
same diet. Authors propose that antibiotic treatment of
healthy animals led to unbalanced, disease- and obese-
related microbiota, that promotes the growth of microor-
ganisms carrying clinically relevant mobile ARGs, and
potentially increasing the risk of transmission of
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antibiotic-resistant bacteria to humans (Dobrzanska
et al., 2020).
The use of antibiotics as a growth promoter agent has
been deemed problematic due to multiple reasons (Sil-
bergeld et al., 2008; Verraes et al., 2013). One of the
most important consequences is the fate of all those
administered antibiotics that are not absorbed by the ani-
mal and dumped into the environment in the way of fae-
ces and urine. This situation, along with the insufficient
treatment of residues from industrial, residential and farm
wastes, contributes to the expansion of the environmen-
tal resistome (Chee-Sanford et al., 2009; Del Fiol et al.,
2018). This resistome is in part due to the influx of ARM
genes from environmental bacteria that can be incorpo-
rated through horizontal gene transfer (HGT) into com-
mensals and pathogenic strains. A recent study by
Mourkas and colleagues in Environmental Microbiology
addresses this topic, providing a basis for understanding
Fig. 1. The One Health approach holds that the health of human beings is connected to the health of animals, plants and our shared environ-
ment. The inner-circle illustrates how antibiotic resistance is spread in a healthy and diverse bacterial population. This figure was made using
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the interaction between different AMR gene pools and
the potential source/sink contribution of livestock,
humans and sewage effluents in the Campylobacter
resistome. In their report, the authors highlight the exis-
tence of multiple HGT events within Campylobacter
strains from the gut microbiome, evidenced by the exis-
tence of genetic islands (GIs) that contain clusters of
genes for resistance to multiple drug classes and that
are shared among isolates from multiple sources (live-
stock, humans and sewage) (Mourkas, et al., 2019).
Given that the effectiveness of an antimicrobial com-
pound is determined by the possible tolerance or resis-
tance of the targeted bacteria, understanding the drivers
of antibiotic resistance and the mechanisms of selection
for resistant bacteria is of vital importance. Mechanisms
of antibiotic resistance have been well documented for
several drug classes. In a nutshell, these mechanisms
block drug function by reducing its intracellular concen-
tration via efflux pumps, reducing the membrane perme-
ability, or modifying the antimicrobial compound or its
target in the cell (Munita and Arias, 2016). However,
there is still a lack of knowledge in certain antibiotic
resistance mechanisms being necessary the devise of
innovative therapeutic approaches. Comparative metabo-
lomics analysis between sensitive and resistant strains
from the same species could help to break ground on
new approaches to eliminate MDR bacteria. In connec-
tion with the latter, the work by Zhang and coworkers
revealed for the first time an unknown metabolic mecha-
nism in Vibrio alginolyticus for gentamicin resistance.
The authors show that gentamicin resistant strains of
Vibrio have mutations on genes related to carbon and
energy metabolism indicating a metabolic shift. Muta-
tions that produce the gentamicin resistance phenotype
affect the energy production of the cell, leading to altered
operation of metabolic pathways such as the pyruvate
cycle and the sodium-pumping NADH: ubiquinone oxi-
doreductase (Na(+)-NQR) system, which in turn
decreased the membrane potential and a concomitant
decrease in the intracellular concentration of gentamicin
(Zhang et al., 2019). Further analysis of the metabolic
profile of gentamycin resistant V. alginolyticus strains
identified glucose as the most down-regulated metabo-
lite, and the authors proposed that glucose in this
microbe can function as an antibiotic resistance-reverting
molecule.
The use of alternative therapies to broad-spectrum
antibiotics such as bacteriocins, CRISPR-Cas antimicro-
bials, bacteriophage therapy, the local release of toxins,
and the use of predatory bacteria have been reported in
recent years (Kadouri et al., 2013; Allen, 2017; Ghosh
et al., 2019). Unfortunately, none of these options have
consistently demonstrated efficacy comparable to antibi-
otic treatments. Given the important interactions between
the different contributions of human, animal and environ-
mental sources to antimicrobial resistance, it is logical to
take into consideration a One Health perspective when
addressing this problem (McEwen and Collignon, 2018).
The One Health approach recognizes that humans, ani-
mals and environmental health are intricately linked,
and, therefore, the control and surveillance of ARG
needs to be regarded in all three sectors (Fig. 1). The
complexities of mechanisms by which microorganisms
can acquire ARGs are driven not only by biological pro-
cesses but it is also affected by socio-economic factors
that should be broken down into its components for their
study, and they should be taken into account to design
of strategies to combat this public health threat. These
factors contribute to genetic selection pressure for the
emergence of MDR bacterial infections in the commu-
nity. Integrated measures of inspection, surveillance,
next-generation sequencing and advanced bioinformatics
tools, while implementing the One Health approach, are
required to better control antibiotic usage in animal pro-
duction, and to reduce contamination and transmission
of MDR strains along the food chain.
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